Merck (MRK) Other Non-Current Liabilities (2009 - 2026)

Merck (MRK) has 17 years of Other Non-Current Liabilities data on file, last reported at $7.6 billion in Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $7.6 billion, up 14.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 billion (up 14.83% YoY), and the FY2025 annual result was $7.7 billion, up 18.92% from the prior year.
• Other Non-Current Liabilities eased to $7.6 billion in Q1 2026 per MRK's latest filing, from $7.7 billion in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $9.7 billion in Q1 2022 and troughed at $208.0 million in Q3 2024.
• A 5-year average of $4.2 billion and a median of $6.5 billion in 2024 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities plunged 97.17% in 2024, then jumped 3583.17% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $8.3 billion in 2022, then plunged by 95.75% to $354.0 million in 2023, then surged by 1726.27% to $6.5 billion in 2024, then increased by 18.92% to $7.7 billion in 2025, then retreated by 0.6% to $7.6 billion in 2026.
• Business Quant data shows MRK's Other Non-Current Liabilities at $7.6 billion in Q1 2026, $7.7 billion in Q4 2025, and $7.7 billion in Q3 2025.